SP-04
Chemotherapy Induced Peripheral Neuropathy (CIPN)
Phase 2Phase 2 in progress in China, US, EU; Non-clinical in Japan
Key Facts
Indication
Chemotherapy Induced Peripheral Neuropathy (CIPN)
Phase
Phase 2
Status
Phase 2 in progress in China, US, EU; Non-clinical in Japan
Company
About Solasia Pharma K.K.
Japanese oncology-focused biopharma company developing and commercializing cancer therapeutics and supportive care products.
View full company profile